About Index Trending news
Analyze
Top 50 Pricing
Syndax

Syndax

Syndax

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.

Elsewhere

Alexa global traffic share

Twitter followers

18 Sep 2014
$4,947,480
Debt financing
27 Aug 2013
$26,600,000
Venture capital (Series B)
16 Mar 2010
$9,000,000
Venture capital (Series A)